Directory of funded grants

Filter by

686 results found

Démêler l’altération du système endocannabinoïde dans la SLA : une nouvelle méthode thérapeutique axée sur la jonction neuromusculaire

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada-Brain Canada Career Transition Award

  • Province

    Québec

  • Start Date

    2025

  • Total Grant Amount

    $250,000

  • Health Canada Contribution

    $125,000

Project Overview

A hallmark and the earliest event taking place in ALS is the denervation of neuromuscular junctions (NMJs), which results in muscle weakness and paralysis. Results from mentor’s lab and others demonstrated that NMJ denervation in ALS is a complex and dynamic process rather than just a manifestation of sudden global…

Linking reduced cell-specific inhibition to abnormal brain activity in chronic stress

  • Grant Type

    Team grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    Brain Canada & Weizmann Institute of Science Team Grants

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $500,000

  • Health Canada Contribution

    $250,000

Project Overview

Depression is a leading cause of disability, with a large proportion of treatment-resistant patients. Recent studies have implicated reduced brain inhibition in human depression from a specific neuron type (SST), and new pharmacology boosting this reduced inhibition led to antidepressant and pro-cognitive effects in rodents. However, establishing a direct link…

Harnessing mRNA translation to increase the neuroprotective potential of disease-associated microglia in neurodegenerative diseases

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Brain Canada & Weizmann Institute of Science Team Grants

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $500,000

  • Health Canada Contribution

    $250,000

Project Overview

Microglia are the brain's immune cells. Research in recent years has revealed their crucial role in preventing the development of neurodegenerative diseases, including Alzheimer's Disease (AD). However, the precise mechanisms by which microglia lose their potency in protecting the brain, enabling the development of AD, are not fully understood. Our…

Deciphering the link between gut bacteria and glymphatics in neurodegeneration

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    Brain Canada & Weizmann Institute of Science Team Grants

  • Province

    Alberta

  • Start Date

    2024

  • Total Grant Amount

    $500,000

Project Overview

Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease in humans. The disease is caused by the degeneration of motor neurons that innervate the voluntary muscles, leading to respiratory failure and death within about 3 years from onset. A central feature of ALS is the abnormal…

Enhancing walking recovery after stroke through a 24-hour behaviour change approach

  • Grant Type

    Capacity building grants

  • Area of research

    Injury

  • Disease Area

    Stroke

  • Province

    Alberta

  • Start Date

    2024

  • Total Grant Amount

    $60,000

  • Health Canada Contribution

    $30,000

Project Overview

We are looking at how a behaviour change program can help stroke survivors recover their ability to walk better. We are aiming to recruit 24 people who have had a stroke within the first week after it happened. These participants need to be at least 18 years old, able to…